公司动态 - 律师事务所Faruqi & Faruqi正在调查Treace Medical Concepts Inc (NASDAQ: TMCI)可能违反联邦证券法的行为 并提醒投资者在2025年6月10日前申请成为集体诉讼的首席原告 [3] - 诉讼指控公司及其高管通过虚假或误导性陈述违反证券法 包括未披露竞争影响其主打产品Lapiplasty 3D Bunion Correction System的需求和使用情况 [5] - 公司2024年5月7日盘后发布新闻稿 将2024年全年收入指引从2.2亿-2.25亿美元下调至2.01亿-2.11亿美元 [6] 财务表现 - 由于竞争加剧 包括微创截骨术和Lapiplasty"仿制品"的冲击 公司收入下降 需要加速推出替代截骨术的产品 [5][6] - 业绩指引下调消息公布后 公司股价在2024年5月8日暴跌6.95美元 跌幅近63% 收于4.17美元 成交量异常放大 [7] 法律程序 - 法院将任命在索赔中拥有最大财务利益的投资者作为首席原告 该投资者需能代表集体诉讼成员并监督诉讼进程 [8] - 律师事务所鼓励知情人士提供有关Treace公司行为的信息 包括举报人、前员工和股东等 [9]

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Treace Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the ...

案件背景 - 罗森律师事务所提醒在2023年5月8日至2024年5月7日期间购买Treace Medical Concepts Inc (NASDAQ: TMCI)证券的投资者注意2025年6月10日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得赔偿而无需支付任何自付费用 [2] 诉讼详情 - 诉讼指控被告在集体诉讼期间做出虚假和/或误导性陈述和/或未能披露以下信息：(1) 竞争影响了其主打产品Lapiplasty 3D拇趾外翻矫正系统的需求和利用率 (2) 因此Treace Medical收入下降并需要加速推出替代截骨术的产品 (3) 被告对Treace Medical业务、运营和前景的积极陈述存在重大误导性且缺乏合理依据 [5] - 当真实情况曝光后投资者遭受了损失 [5] 律所资质 - 罗森律师事务所在证券集体诉讼领域具有丰富经验曾创下针对中国公司的最大证券集体诉讼和解金额纪录 [4] - 该律所2017年在ISS证券集体诉讼服务排名中位列第一自2013年以来每年都保持前四名已为投资者追回数亿美元2019年单年为投资者获得超过4.38亿美元赔偿 [4] - 创始合伙人Laurence Rosen被Law360评为原告律师界泰斗多位律师获得Lawdragon和超级律师认可 [4]

NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the "Class Period"), of the important June 10, 2025 lead plaintiff deadline.So what: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.W ...

NEW YORK, May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=150492&from=4CLASS PE ...

NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. (NASDAQ: TMCI) between May 8, 2023 and May 7, 2024, both dates inclusive (the “Class Period”), of the important June 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Treace Medical securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrang ...

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) securities between May 8, 2023 and May 7, 2024. The Company is focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. T ...

NEW YORK, May 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI).Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=149528&from=4CLASS PE ...

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI). Shareholders who purchased shares of TMCI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/treace-medical-concepts-inc-loss-submission-form-2/?id=149362&from=3 ...

案件概述 - Rosen Law Firm提醒在2023年5月8日至2024年5月7日期间购买Treace Medical Concepts Inc证券的投资者注意2025年6月10日的首席原告截止日期 [1] - 投资者可能有权通过应急费用安排获得补偿而无需支付任何自付费用 [2] - 已提起集体诉讼，投资者可通过指定链接或联系方式加入 [3][6] 律所背景 - Rosen Law Firm专注于证券集体诉讼和股东衍生诉讼，曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 该律所2017年在ISS证券集体诉讼服务中排名第一，自2013年以来每年位列前四，2019年为投资者追回超过4.38亿美元 [4] - 创始合伙人Laurence Rosen被Law360评为原告律师界泰斗，多名律师获得Lawdragon和Super Lawyers认可 [4] 诉讼细节 - 指控称被告在集体诉讼期间作出虚假或误导性陈述，未披露竞争影响其主打产品Lapiplasty 3D Bunion Correction System的需求和使用 [5] - 由于竞争导致收入下降，公司需加速推出替代截骨术的产品计划 [5] - 被告对业务运营和前景的积极陈述被指缺乏合理依据，真相披露后投资者遭受损失 [5] 参与方式 - 投资者可通过指定网址、电话或邮箱联系Phillip Kim律师参与集体诉讼 [3][6] - 首席原告需在2025年6月10日前向法院提出申请，但投资者是否担任首席原告不影响未来潜在赔偿份额 [3][7] - 投资者可选择自行聘请律师或保持缺席成员身份 [7]